A Phase II Trial of Abemaciclib in Patients with P16ink4a Negative, Relapsed Mesothelioma.
Journal of Clinical Oncology(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined